Condo housing could be part of the housing affordability solution

System Is Shutting the Door on Condo Ownership

Condominiums are often the most affordable path to homeownership, yet the condo market is stalling. An Urban Institute report says broken approval rules and rising insurance costs are choking financing.

B&W photo of wedding couples hands. A black man's hand and a white woman's hand clasp each other.

Why Are Black-White Marriage Rates So Low?

Why do Americans so rarely marry across race and class lines? A new Census-linked study of 31 million people finds residential segregation explains over a third of class-based marriage sorting but less than 5% of racial sorting. Desegregation could boost interclass marriage, while barriers to interracial marriage run far deeper than neighborhoods.

A security guard shining flashlight up a stairwell.

The Working Poor Security Guards Who Protect Everyone Else’s Safety

A new UC Berkeley Labor Center analysis profiles California’s 186,000 security guards. Most earn below a living wage, over half the low-wage tier lack employer health insurance, and annual turnover nears 92 percent. Researchers link that churn to weaker safety, citing airport screening data. The workforce is overwhelmingly people of color.

Futuristic humanoid with glowing features. This represents the AI usage statistics showing Americans use AI more than ever but trust it less.

AI Usage Stats 2026: Americans Use It More but Trust It Less

About half of U.S. adults now use AI chatbots, roughly double the 2024 share. But a new Pew Research Center survey finds views tilting negative. Most say AI is moving too fast and will make their data less secure. Even younger adults, the heaviest users, are the most skeptical about AI’s future impact.

Red CAR macrophages attacking blue cancer cells

The Immune Cell That Could Make CAR Macrophage Therapy Renewable

Engineered macrophages struggle to expand and persist as cancer therapies. USC researchers found a way to grow their upstream progenitors on a massive scale by blocking one enzyme. CAR-engineered versions attacked leukemia and solid tumors in mice. A new receptor design even recruited the host’s immune system across mismatch barriers.